Top Pharmaceuticals companies in United States by Shares (Diluted, Weighted)

This ranking features the top 665 Pharmaceuticals companies in United States ranked by Shares (Diluted, Weighted), averaging a Shares (Diluted, Weighted) of 112,718,600, for January 15, 2025.

United States

Pharmaceuticals

#	Name	Shares (Diluted, Weighted)	Reported Date	Stock Price	Change	Country
1	Pfizer Inc. 1 PFE	5,686,250,000	Sept. 29, 2024	USD 26.41	-1.46%	United States
2	Merck & Co., Inc. 2 MRK	2,545,791,666	Sept. 30, 2024	USD 99.65	-1.32%	United States
3	Johnson & Johnson 3 JNJ	2,427,675,000	Sept. 29, 2024	USD 144.75	0.19%	United States
4	Bristol-Myers Squibb Company 4 BMY	2,029,000,000	Sept. 30, 2024	USD 55.74	0.69%	United States
5	AbbVie Inc. 5 ABBV	1,772,000,000	Sept. 30, 2024	USD 175.55	-0.67%	United States
6	Abbott Laboratories 6 ABT	1,749,250,000	Sept. 30, 2024	USD 113.02	-0.15%	United States
7	Boston Scientific Corporation 7 BSX	1,482,550,000	Sept. 30, 2024	USD 95.65	1.10%	United States
8	CVS Health Corporation 8 CVS	1,269,500,000	Sept. 30, 2024	USD 51.57	0.10%	United States
9	Gilead Sciences, Inc. 9 GILD	1,252,000,000	Sept. 30, 2024	USD 91.00	1.18%	United States
10	Viatris Inc. 10 VTRS	1,200,275,000	Sept. 30, 2024	USD 11.72	-0.68%	United States
11	UnitedHealth Group Incorporated 11 UNH	928,750,000	Sept. 30, 2024	USD 543.74	0.48%	United States
12	Eli Lilly and Company 12 LLY	915,595,250	Sept. 30, 2024	USD 744.91	-6.59%	United States
13	Colgate-Palmolive Company 13 CL	824,300,000	Sept. 30, 2024	USD 87.67	0.65%	United States
14	OPKO Health, Inc. 14 OPK	788,490,918	Sept. 30, 2024	USD 1.48	-3.27%	United States
15	Danaher Corporation 15 DHR	741,625,000	Sept. 27, 2024	USD 237.62	-0.94%	United States
16	ImmunityBio, Inc. 16 IBRX	682,149,430	Sept. 30, 2024	USD 2.32	-6.45%	United States
17	Avantor, Inc. 17 AVTR	681,550,000	Sept. 30, 2024	USD 21.72	-1.36%	United States
18	Olaplex Holdings, Inc. 18 OLPX	665,126,346	Sept. 30, 2024	USD 1.54	1.99%	United States
19	MultiPlan Corporation 19 MPLN	646,003,323	Sept. 30, 2024	USD 15.00	2.04%	United States
20	Geron Corporation 20 GERN	628,633,528	Sept. 30, 2024	USD 2.94	-1.34%	United States
21	Edwards Lifesciences Corporation 21 EW	603,350,000	Sept. 30, 2024	USD 71.04	-0.07%	United States
22	Royalty Pharma plc 22 RPRX	558,421,466	Sept. 30, 2024	USD 30.03	0.13%	United States
23	Amgen Inc. 23 AMGN	539,750,000	Sept. 30, 2024	USD 267.10	-1.14%	United States
24	Centene Corporation 24 CNC	532,492,750	Sept. 30, 2024	USD 63.40	-0.47%	United States
25	Baxter International Inc. 25 BAX	509,750,000	Sept. 30, 2024	USD 30.62	0.39%	United States
26	Summit Therapeutics Inc. 26 SMMT	496,170,061	Sept. 30, 2023	USD 16.65	-8.42%	United States
27	Elanco Animal Health Incorporated 27 ELAN	495,175,000	Sept. 30, 2024	USD 11.70	NA	United States
28	GE HealthCare Technologies Inc. 28 GEHC	458,750,000	Sept. 30, 2024	USD 84.13	-1.40%	United States
29	Zoetis Inc. 29 ZTS	457,100,000	Sept. 30, 2024	USD 164.41	-1.15%	United States
30	DexCom, Inc. 30 DXCM	414,900,000	Sept. 30, 2024	USD 79.17	-0.84%	United States
31	GoodRx Holdings, Inc. 31 GDRX	391,633,000	Sept. 30, 2024	USD 4.15	-1.66%	United States
32	Moderna, Inc. 32 MRNA	390,000,000	Sept. 30, 2024	USD 34.46	-1.96%	United States
33	Thermo Fisher Scientific Inc. 33 TMO	384,750,000	Sept. 28, 2024	USD 556.99	0.27%	United States
34	Intuitive Surgical, Inc. 34 ISRG	360,600,000	Sept. 30, 2024	USD 538.88	-0.16%	United States
35	Renalytix Plc 35 RENX.L	324,538,098	June 30, 2024	USD 0.15	0.09%	United States
36	MannKind Corporation 36 MNKD	301,590,500	Sept. 30, 2024	USD 6.03	-1.63%	United States
37	Amicus Therapeutics, Inc. 37 FOLD	301,240,434	Sept. 30, 2024	USD 9.21	-0.22%	United States
38	Exelixis, Inc. 38 EXEL	301,001,250	Sept. 27, 2024	USD 35.65	0.99%	United States
39	Amneal Pharmaceuticals, Inc. 39 AMRX	294,898,500	Sept. 30, 2024	USD 7.85	1.68%	United States
40	Agilent Technologies, Inc. 40 A	291,250,000	Oct. 31, 2024	USD 143.43	1.04%	United States
41	Becton, Dickinson and Company 41 BDX	290,649,250	Sept. 30, 2024	USD 235.80	-0.17%	United States
42	Cigna Corporation 42 CI	286,619,500	Sept. 30, 2024	USD 285.03	0.91%	United States
43	Sotera Health Company 43 SHC	284,376,500	Sept. 30, 2024	USD 12.76	-2.52%	United States
44	Standard BioTools Inc. 44 LAB	279,430,750	Sept. 30, 2024	USD 2.01	-2.43%	United States
45	Iovance Biotherapeutics, Inc. 45 IOVA	277,564,250	Sept. 30, 2024	USD 5.89	1.90%	United States
46	PureTech Health plc 46 PRTC.L	276,302,533	Dec. 31, 2023	USD 1.72	1.09%	United States
47	Oscar Health, Inc. 47 OSCR	266,987,265	Sept. 30, 2024	USD 14.93	5.36%	United States
48	Vertex Pharmaceuticals Incorporated 48 VRTX	260,274,999	Sept. 30, 2024	USD 411.66	-0.41%	United States
49	Organon & Co. 49 OGN	258,326,749	Sept. 30, 2024	USD 15.81	0.96%	United States
50	Polarean Imaging plc 50 POLX.L	251,207,277	Dec. 31, 2023	USD 0.02	0.09%	United States

1 2 3 4 … 14

Frequently Asked Questions

Which Pharmaceuticals company in United States has the highest Shares (Diluted, Weighted) ?

The Pharmaceuticals company in United States with the highest Shares (Diluted, Weighted) is Pfizer Inc. (NYSE: PFE) at 5,686,250,000.
Which Pharmaceuticals company in United States has the lowest Shares (Diluted, Weighted) ?

The Pharmaceuticals company in United States with the lowest Shares (Diluted, Weighted) is Cingulate Inc. (NasdaqCM: CING) at 56,333.

What are the top 10 Pharmaceuticals companies in United States by Shares (Diluted, Weighted) ?

The top 10 Pharmaceuticals companies in United States by Shares (Diluted, Weighted) are Pfizer Inc., Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb Company, AbbVie Inc., Abbott Laboratories, Boston Scientific Corporation, CVS Health Corporation, Gilead Sciences, Inc. and Viatris Inc..
What are the bottom 10 Pharmaceuticals companies in United States by Shares (Diluted, Weighted) ?

The bottom 10 Pharmaceuticals companies in United States by Shares (Diluted, Weighted) are Cingulate Inc., Palisade Bio, Inc., ReShape Lifesciences Inc., Nuwellis, Inc., Allarity Therapeutics, Inc., iSpecimen Inc., Phio Pharmaceuticals Corp., Sintx Technologies, Inc., Cemtrex, Inc. and 180 Life Sciences Corp..